Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating activities:
Net income	$ 3,209	$ 2,570
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,023	409
Amortization of debt discount	14	6
Provision for (recovery of) bad debt expense	25	(33)
Share-based compensation	1,164	200
Inventory reserve	77	(27)
Provision for deferred income taxes	388	89
(Increase) decrease in operating assets:
Accounts receivable	(1,630)	(209)
Inventories	(900)	(376)
Vendor deposits	278	1,484
Costs in excess of billings on uncompleted contracts	(2,792)	519
Other assets	(731)	270
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	(4,327)	(548)
Accrued employee expenses	1,261	(311)
Customer deposits	1,917	(1,597)
Billings in excess of costs on uncompleted contracts	(466)	1,167
Net cash (used) provided by operating activities	(1,490)	3,613
Investing activities:
Capital expenditures	(395)	(123)
Cash paid for acquisition, net of cash acquired	(13,352)	(13,394)
Net cash used by investing activities	(13,747)	(13,517)
Financing activities:
Dividends paid	(1,403)	(1,040)
Proceeds from borrowings	58,387	25,938
Debt repayments	(40,650)	(21,236)
Proceeds from issuance of common shares to related party		6,000
Payment of debt issuance costs		(88)
Purchase of vested shares	(303)
Net cash provided by financing activities	16,031	9,574
Net increase (decrease) in cash and cash equivalents	794	(330)
Cash and cash equivalents at beginning of period	727	3,942
Cash and cash equivalents at end of period	1,521	3,612
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	300	72
Cash paid during the period for income taxes	855	1,370
Supplemental disclosure of non-cash financing activities
Common stock issued for acquisitions	$ 21,376	$ 16,053